Réaction #41070

ord-d9581f75adf6464a92654b852e2ab049

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Autreirradiated at 130° C. for 3 hours
  2. 2
    AutreThe solvent was removed under vacuum
  3. 3
    Autrethe residue was partitioned between water and ethyl acetate
  4. 4
    AutreThe organic phase was evaporated
  5. 5
    workup.DISSOLUTIONthe crude dissolved in dichloromethane
  6. 6
    workup.ADDITIONtreated with PS-isocyanate resin (400 mg)
  7. 7
    FiltrationAfter filtration
  8. 8
    Autrethe solvent was evaporated
  9. 9
    Autrethe crude purified by preparative LC-MS
  10. 10
    Lavageeluting with MeOH
  11. 11
    Autrethe product obtained

Mode opératoire

A solution of 1-(4-chloro-butyl)-5-(2,4-dimethyl-oxazol-5-yl)-1H-pyrimidine-2,4-dione (Prep65, 100 mg, 0.34 mmol), (1S,5R)-1-(4-trifluoromethyl-phenyl)-3-aza-bicyclo[3.1.0]hexane (Prep4, 68 mg, 0.3 mmol), and DIPEA (130 mg, 1 mmol) in absolute EtOH (3 ml) was placed in a microwave oven and irradiated at 130° C. for 3 hours. The solvent was removed under vacuum and the residue was partitioned between water and ethyl acetate. The organic phase was evaporated, the crude dissolved in dichloromethane and treated with PS-isocyanate resin (400 mg) under stirring for 3 h. After filtration, the solvent was evaporated and the crude purified by preparative LC-MS. The residue was loaded over a SCX cartridge eluting with MeOH and the product obtained was treated with 4N HCl in dioxane (1 eq), to give the title compound as a white powder. (43 mg, 24% yield).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US07727988B2uspto-grants-2010_06